Michael Okunewitch

Stock Analyst at Maxim Group

(0.42)
# 2,462
Out of 4,494 analysts
15
Total ratings
14.29%
Success rate
-15.8%
Average return
Main Sectors:
Top Industries:

12 Stocks

Chemomab Therapeutics
May 13, 2024
Initiates: Buy
Price Target: $4
Current: $1.12
Upside: +257.46%
Lexaria Bioscience
Mar 5, 2024
Maintains: Buy
Price Target: $3$12
Current: $2.97
Upside: +304.04%
Acrivon Therapeutics
Oct 5, 2023
Initiates: Buy
Price Target: $24
Current: $7.94
Upside: +202.27%
Anebulo Pharmaceuticals
Sep 21, 2023
Initiates: Buy
Price Target: $6
Current: $2.41
Upside: +148.96%
Kiora Pharmaceuticals
Aug 9, 2023
Maintains: Buy
Price Target: $108$18
Current: $4.29
Upside: +319.58%
Alzamend Neuro
Apr 12, 2023
Initiates: Buy
Price Target: $23
Current: $3.97
Upside: +466.75%
MediWound
Dec 22, 2022
Initiates: Buy
Price Target: $25
Current: $20.79
Upside: +20.25%
BioRestorative Therapies
Sep 28, 2022
Initiates: Buy
Price Target: $6
Current: $1.75
Upside: +242.86%
HCW Biologics
Mar 24, 2022
Initiates: Buy
Price Target: $4
Current: $0.69
Upside: +483.09%
Longeveron
Mar 24, 2022
Initiates: Buy
Price Target: $140
Current: $3.52
Upside: +3,877.27%
Atai Life Sciences
Nov 30, 2021
Initiates: Buy
Price Target: n/a
Current: $1.64
Upside: -
Citius Pharmaceuticals
Nov 30, 2021
Initiates: Buy
Price Target: n/a
Current: $0.85
Upside: -